A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence
Open Access
- 4 November 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (21) , 6927
Abstract
A PRoliferation-Inducing Ligand (APRIL), the thirteenth member of the tumor necrosis factor superfamily, plays a key role in the regulation of activated B cells, the survival of long-lived plasma cells, and immunoglobulin (Ig) isotype class switching. Several lines of evidence have implicated APRIL in the pathogenesis of IgA nephropathy (IgAN). Globally, IgAN is the most common primary glomerulonephritis, and it can progress to end-stage kidney disease; yet, disease-modifying treatments for this condition have historically been lacking. The preliminary data in ongoing clinical trials indicate that APRIL inhibition can reduce proteinuria and slow the rate of kidney disease progression by acting at an upstream level in IgAN pathogenesis. In this review, we examine what is known about the physiologic roles of APRIL and evaluate the experimental and epidemiological evidence describing how these normal biologic processes are thought to be subverted in IgAN. The weight of the preclinical, clinical, and genetic data supporting a key role for APRIL in IgAN has galvanized pharmacologic research, and several anti-APRIL drug candidates have now entered clinical development for IgAN. Herein, we present an overview of the clinical results to date. Finally, we explore where more research and evidence are needed to transform potential therapies into clinical benefits for patients with IgAN.Keywords
Funding Information
- Otsuka Pharmaceutical Development & Commercialization, Inc.
This publication has 123 references indexed in Scilit:
- The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progressionKidney International, 2012
- Association of Common Variants in TNFRSF13B, TNFSF13, and ANXA3 with Serum Levels of Non-Albumin Protein and Immunoglobulin Isotypes in JapanesePLOS ONE, 2012
- Clinical significance of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationThe Korean Journal of Hematology, 2011
- HLA Has Strongest Association with IgA Nephropathy in Genome-Wide AnalysisJournal of the American Society of Nephrology, 2010
- Synovial tissues concentrate secreted APRILArthritis Research & Therapy, 2009
- BAFF: a local and systemic target in autoimmune diseasesClinical and Experimental Immunology, 2009
- The BLyS Family: Toward a Molecular Understanding of B Cell HomeostasisCell Biochemistry and Biophysics, 2008
- The regulation of IgA class switchingNature Reviews Immunology, 2008
- High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiencyClinical Immunology, 2007
- RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILNature Immunology, 2002